|
| | Issue Date | Title | Author(s) |
| 61 | Nov-2015 | Development of Potent Adenosine Monophosphate Activated Protein Kinase (AMPK) Activators | Fang, Chun-Sheng; Lai, Po-Ting; Kulp, Samuel K; Serya, Rabah ; Ismail, Nasser S M; Chen, Ching-Shih; Dokla, Eman ; Khaled A M Abouzid |
| 62 | 15-Feb-2022 | Discovery of a benzimidazole-based dual FLT3/TrKA inhibitor targeting acute myeloid leukemia | Dokla, Eman ; Abdel-Aziz, Amal Kamal; Milik, Sandra N.; McPhillie, Martin J.; Minucci, Saverio; Khaled A M Abouzid |
| 63 | Dec-2022 | Discovery of EMD37, a 1,2,4-oxadiazole derivative, as a novel endoplasmic reticulum stress inducer with potent anticancer activity | Abdel-Aziz, Amal Kamal ; Khaled A M Abouzid ; Minucci, Saverio; Dokla, Eman |
| 64 | Apr-2014 | Discovery of new HER2/EGFR dual kinase inhibitors based on the anilinoquinazoline scaffold as potential anti-cancer agents | Sadek, Maiada M; Serya, Rabah ; Kafafy, Abdel-Hamid N; Ahmed, Marawan; Wang, Feng; Khaled A M Abouzid |
| 65 | Dec-2015 | Discovery of Novel Peptidomimetics as Irreversible CHIKV NsP2 Protease Inhibitors Using Quantum Mechanical-Based Ligand Descriptors | El-labbad, Eman M; Ismail, Mohammed A H; Abou Ei Ella, Dalal A; Ahmed, Marawan; Wang, Feng; Barakat, Khaled H; Abouzid, Khaled |
| 66 | 21-Oct-2016 | Discovery of novel Tetrahydrobenzo[b]thiophene and pyrrole based scaffolds as potent and selective CB2 receptor ligands: The structural elements controlling binding affinity, selectivity and functionality | Osman, Noha A; Ligresti, Alessia; Klein, Christian D; Allarà, Marco; Rabbito, Alessandro; Di Marzo, Vincenzo; Abouzid, Khaled ; Abadi, Ashraf H |
| 67 | Jun-2015 | Discovery of novel tricyclic pyrido[3',2':4,5]thieno[3,2-d]pyrimidin-4-amine derivatives as VEGFR-2 inhibitors | Abdel Aziz, Yasmine M; Said, Mohamed M; El Shihawy, Hosam A; Abouzid, Khaled |
| 68 | 2015 | Discovery of Potent Antiproliferative Agents Targeting EGFR Tyrosine Kinase Based on the Pyrido[3',2':4,5]thieno[3,2-d]pyrimidin-4-amine Scaffold | Aziz, Yasmine Mohamed Abdel; Said, Mohamed Mokhtar; El Shihawy, Hosam Ahmed; Tolba, Mai ; Abouzid, Khaled |
| 69 | Aug-2021 | Discovery of potent thieno[2,3-d]pyrimidine VEGFR-2 inhibitors: Design, synthesis and enzyme inhibitory evaluation supported by molecular dynamics simulations | Elrazaz, Eman ; Serya, Rabah A T; Ismail, Nasser S M; Albohy, Amgad; Abou El Ella, Dalal ; Khaled A M Abouzid |
| 70 | 15-Apr-2016 | Discovery of Potent VEGFR-2 Inhibitors based on Furopyrimidine and Thienopyrimidne Scaffolds as Cancer Targeting Agents | Aziz, Marwa A; Serya, Rabah A T; Lasheen, Deena S. ; Abdel-Aziz, Amal Kamal ; Mansour, Ahmed M; Ahmed Esmat ; Singab A. ; Khaled A M Abouzid |
| 71 | 7-Jul-2017 | Eco-friendly synthesis of novel cyanopyridine derivatives and their anticancer and PIM-1 kinase inhibitory activities | Abouzid, Khaled ; Al-Ansary, Ghada H; El- naggar, Abeer |
| 72 | 26-Aug-2020 | Elaborating piperazinyl-furopyrimidine based scaffolds as phosphoinositol-3-kinase enzyme alpha (PI3Kα) inhibitors to combat pancreatic cancer | Mansour, Mai A; Lasheen, Deena S. ; Gaber, Hatem M; Khaled A M Abouzid |
| 73 | 2016 | Furo[2,3-d]pyrimidine based derivatives as kinase inhibitors and anticancer agents | Aziz, M.A. ; Serya, RAT; Lasheen, DS; Abouzid, Khaled |
| 74 | Feb-2021 | Green analysis of newly approved binary omeprazole/aspirin mixture in presence of aspirin impurity using ultra-high-performance liquid chromatography and thin-layer chromatography methods | Abdelaleem, Eglal A; Abou El Ella, Dalal ; Mahmoud, Alaa M; Abdelhamid, Nessreen S |
| 75 | 2022 | Hands-on synthetic approaches and biological activities of anthranilic acid derivatives: A mini-review | Nasr, Tamer; Aboshanab, Ahmed; Abouzid, Khaled ; Zaghary, Wafaa |
| 76 | 25-Oct-1996 | Head group analogs of arachidonylethanolamide, the endogenous cannabinoid ligand | Khanolkar, A D; Abadji, V; Lin, S; Hill, W A; Taha, G; Abouzid, Khaled ; Meng, Z; Fan, P; Makriyannis, A |
| 77 | 15-Dec-2017 | How to train your inhibitor: Design strategies to overcome resistance to Epidermal Growth Factor Receptor inhibitors | Milik, Sandra N; Lasheen, Deena S; Serya, Rabah ; Abouzid, Khaled A M; Khaled A M Abouzid |
| 78 | 13-Nov-2018 | Hypoxia-mediated mitochondria apoptosis inhibition induces temozolomide treatment resistance through miR-26a/Bad/Bax axis | Ge, Xin; Pan, Min-Hong; Wang, Lin; Li, Wei; Jiang, Chengfei; He, Jun; Abouzid, Khaled ; Liu, Ling-Zhi; Shi, Zhumei; Jiang, Bing-Hua |
| 79 | Mar-2022 | Identification of a promising hit from a new series of pyrazolo[1,5-a]pyrimidine based compounds as a potential anticancer agent with potent CDK1 inhibitory and pro-apoptotic properties through a multistep in vitro assessment | Elgiushy, Hossam R; Mohamed, Sameh H; Sawaf, Hussein; Hassan, Zeinab; Abou-Taleb, Nageh A; El-Labbad, Eman M; Hassan, Ashraf S; Abouzid, Khaled A M; Abouzid, Khaled ; Ali Taha, Heba |
| 80 | Dec-2018 | Identification of new pyrrolo[2,3-d]pyrimidines as potent VEGFR-2 tyrosine kinase inhibitors: Design, synthesis, biological evaluation and molecular modeling | Adel, Mai; Serya, Rabah ; Lasheen, Deena S. ; Khaled A M Abouzid |
